Cas:59237-50-2 Methyl5-amino-6-methoxypyridine-3-carboxylate manufacturer & supplier

We serve Chemical Name:Methyl5-amino-6-methoxypyridine-3-carboxylate CAS:59237-50-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl5-amino-6-methoxypyridine-3-carboxylate

Chemical Name:Methyl5-amino-6-methoxypyridine-3-carboxylate
CAS.NO:59237-50-2
Synonyms:Methyl 5-amino-6-methoxynicotinate;methyl 5-amino-6-methoxypyridine-3-carboxylate;3-Pyridinecarboxylic acid, 5-amino-6-methoxy-, methyl ester;Methyl5-amino-6-methoxypyridine-3-carboxylate
Molecular Formula:C8H10N2O3
Molecular Weight:182.177
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:334.8±37.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.554
PSA:74.44000
Exact Mass:182.069138
LogP:1.23

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl 5-amino-6-methoxynicotinate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl5-amino-6-methoxypyridine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl5-amino-6-methoxypyridine-3-carboxylate Use and application,methyl 5-amino-6-methoxypyridine-3-carboxylate technical grade,usp/ep/jp grade.


Related News: Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. nona-1,2,3,4,5,6,7,8-octaen-1-ylidene-l2-germane manufacturers Wavelength, a more than 30-year-old firm based in Petah Tikva, launched its API CDMO business in early 2020 and currently sports more than 250 customers from 50 countries. (3-Chloro-propyl)-thiophosphoramidic acid O,O’-diethyl ester suppliers Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. (S)-2-Acetylamino-4-((S)-3-acetylamino-3-methoxycarbonyl-propyldisulfanyl)-butyric acid methyl ester vendor & factory.